JSSH
BIIB icon

J. Safra Sarasin Holding’s Biogen BIIB Stock Holding History

J. Safra Sarasin Holding’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Sell
4,895
-103
-2% -$19.7K 0.01% 390
2026
Q1 		$915K Sell
4,998
-1,476
-23% -$272K 0.02% 305
2025
Q4 		$1.14M Sell
6,474
-2,607
-29% -$426K 0.02% 270
2025
Q3 		$1.27M Buy
9,081
+6,707
+283% +$907K 0.02% 274
2025
Q2 		$298K Sell
2,374
-7,635
-76% -$951K 0.01% 430
2025
Q1 		$1.37M Sell
10,009
-52,864
-84% -$7.56M 0.02% 276
2024
Q4 		$9.61M Sell
62,873
-9,745
-13% -$1.64M 0.16% 114
2024
Q3 		$14.1M Buy
72,618
+6,860
+10% +$1.44M 0.24% 94
2024
Q2 		$15.2M Buy
+65,758
New +$14.3M 0.28% 85

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

J. Safra Sarasin Holding's BIIB Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Biogen (BIIB) stake by 2.1% in Q2 2026, selling an estimated $19.7K and leaving 4,895 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #390.

J. Safra Sarasin Holding first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.2M in Q2 2024. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • J. Safra Sarasin Holding held 4,895 shares of Biogen worth $1M as of Q2 2026.
  • J. Safra Sarasin Holding sold 103 Biogen shares in Q2 2026, an estimated $19.7K.
  • Biogen made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #390 holding.
  • J. Safra Sarasin Holding first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
  • J. Safra Sarasin Holding's Biogen position peaked at $15.2M in Q2 2024.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.